Clinical Trial Update: Intermediate Expanded Access Protocol CNMAu8.EAP04

View source ↗

Summary

This update notes that the intermediate expanded access protocol CNMAu8.EAP04 for Amyotrophic Lateral Sclerosis is temporarily not available. The protocol conce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• CNM-Au8 (CNM-Au8)

Snippet

Sponsor: Clene Nanomedicine | Conditions: ALS, Amyotrophic Lateral Sclerosis | Status: TEMPORARILY_NOT_AVAILABLE